Greater Manchester Medicines Management Group

Greater Manchester Clinical Standards Board

NHS

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website on a monthly basis

October 2019

 

Pathways and Guidelines Development Subgroup (PaGDSG)

16.10.19

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Penicillamine for Rheumatoid Arthritis or Wilsons disease in Adults is in development. We now seek comments on this draft. This consultation period is open until 5pm Wednesday 27th November.

High Cost Drugs Subgroups

16.10.19

A ustekinumab Crohns disease commissioning statement is available for consultation. We now seek comments on this document. This consultation period is open until 5pm Wednesday 27th November.

16.10.19

A liothyronine injection commissioning statement is available for consultation. We now seek comments on this document. This consultation period is open until 5pm Wednesday 27th November.

2.10.19

With the support of the GMMMG High Cost Drugs Subgroups, a revised GMMMG pathway for High Cost Drugs for Treatment of Psoriasis in Adults has been developed and is now open for comment. The draft pathway plus consultation notes are available through this consultation which runs until  5pm Wednesday 13th November. Following consultation and consideration of the comments received GMMMG will finalise a pathway to be recommended to GM Directors of Commissioning for GM wide implementation, therefore all comments are welcomed. The consultation is open until 5pm Wednesday 13th November.

Formulary and Managed Entry Subgroup (FMESG)

1.10.19

The following FMESG actions for September 2019 have been proposed and will be sent to CSB for support. We now seek comments on these proposals. This consultation is open until 5pm on Tuesday 12th November.

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer